Clinical Trial Update: Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral atogepant in adults with menstrual migraine to assess adverse events and changes in disease activity. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

Sponsor: AbbVie | Conditions: Menstrual Migraine (MM) | Phase 3 | Status: RECRUITING